- AU$227.72m
- AU$213.22m
- NZ$84.70m
- 80
- 45
- 52
- 64
Annual balance sheet for Aroa Biosurgery, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 37 | 57.4 | 45.9 | 30.2 | 22.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7.23 | 17.2 | 25.7 | 28.9 | 35.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 48.7 | 79.9 | 78.1 | 69 | 68.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12.7 | 15.4 | 20.6 | 22.2 | 21.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 79.7 | 113 | 117 | 111 | 109 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 15.3 | 6.71 | 7.91 | 9.51 | 10.3 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 21.2 | 12.2 | 14.6 | 16.1 | 15.8 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 58.5 | 100 | 102 | 94.9 | 93.1 |
| Total Liabilities & Shareholders' Equity | 79.7 | 113 | 117 | 111 | 109 |
| Total Common Shares Outstanding |